Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20190430043431N1Phase 3Completed
Phase 3, triple-blind trial of nifedipine in gingival recession (2 arms), sponsored by Babol University of Medical Sciences. Primary endpoints: Landry healing index, Manchester scar scale/index and 1 more. Started Mar 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20190430043431N1.